Lower riskDrug recall · FDA · Published February 3, 2026
Annora Pharma Pitavastatin Tablets 2mg Recall: Foreign Tablets Found
Annora Pharma recalls 2mg Pitavastatin tablets due to foreign tablets found in some bottles. This is a prescription-only product with a specific lot number and expiration date.
“Annora Pharma Pitavastatin Tablets 2mg Recall: Foreign Tablets Found.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31493-annora-pharma-pitavastatin-tablets-2mg-recall-foreign-tablets-found. Based on FDA recall #D-0391-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0391-2026%22&limit=1).
The FDA announced on Feb. 3, 2026, that Annora Pharma Private Limited is recalling Pitavastatin Tablets, 2 mg, due to the presence of foreign tablets. The hazard involves one Pitavastatin 1mg tablet found in a bottle of 2mg tablets.
How to tell if you have it
Brand: Annora Pharma
Product: Pitavastatin Tablets, 2 mg
Packaging: 90-count bottles
NDC: 72603-479-01
Lot #: A252487
Expiration: 05/31/2027
Quantity: 770 bottles
Distribution: Tennessee
The hazard
The recall addresses the presence of foreign tablets, specifically one Pitavastatin 1mg tablet found in a bottle of Pitavastatin 2mg tablets. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Annora Pharma Private Limited has one other recall on record since June 4, 2026. Other recent recalls of similar products include Granules Pharmaceuticals Trazodone 50mg Recall (Jan. 26, 2026), Bionpharma Divalproex Tablets Recall (June 26, 2026), and Golden State Baclofen Tablets Recall (Nov. 26, 2025).
How to tell if you have this one
Check for the lot number A252487 on the bottle. The product was manufactured for Northstar Rx LLC in Memphis, TN and expires May 31, 2027.
Brand
Annora Pharma
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the lot number A252487 on the bottle to confirm if it's recalled.
Where it went and when
Where it was distributed
Distributed in Tennessee.
Listed by the agency
Not listed
FDA distribution: “TN” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Tennessee.
Recall timeline
FDA published this recall 50 days after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0391-2026 (February 3, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0391-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.